Best Stocks Under $2.00 for 2021

The stock market has had an incredible bull-run since the Great Recession of 2008 and 2009. Stocks continue to hit new all-time highs and the price-to-earnings ratios of most S&P 500 companies look very expensive. Many investors are having trouble finding low-priced stocks that haven't already appreciated greatly during the last decade. It's hard to find a good deal on Wall Street right now when even small S&P 500 companies are trading at market caps above $1 billion.

Stocks have gotten expensive both in-terms of share price and their valuation relative to earnings. In more normal markets, a typical S&P 500 company has traded at about fifteen times their earnings. Most stocks are currently trading closer to 25 times their annual earnings. While the stock market has become more expensive as a whole, there are still a handful of undervalued stocks that are trading at less than $2.00 per share.

Value investing opportunities do exist if you're looking in the right places. Putting together a list of the best stocks under $2.00 requires investors to look at smaller and riskier companies and in sectors that are either undiscovered or unloved by the market as a whole. Some of these cheap stocks may not look especially attractive today, but long-term investors will profit if they are willing to exercise patience and hold on to shares of these comapnies through multiple economic cycles.

Some of these companies are solid investing ideas because they are too little and considered too risky to attract the interest of most managed mutual funds and Wall Street money managers. Others operate in unloved and untested areas of the market. You may find even find crypto stocks, marijuana stocks and bitcoin stocks on this list. Others have been beat up by Mr. Market after a long period of slowing profits, but are now actively trying to turn around their business and bounce back. These low-priced stocks operate in a lot of different industries, but these picks all carry two common characteristics. They all have a super-low share price of $2.00 or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

#1 - Calibre Mining

OTCMKTS:CXBMF
Stock Price: $1.29 (-$0.01)
Average Trading Volume: 100,187 shares
Consensus Rating: Buy (4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.58 (100.3% Upside)

Calibre Mining Corp., together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties in Nicaragua. It explores for gold, silver, and copper deposits. The company holds a 100% interest in the Borosi Gold-Silver-Copper Project located in the North Atlantic Autonomous Region of Nicaragua, Central America; and 100% interest in mineral concessions covering an area of 667 square kilometers in the mining triangle of northeast Nicaragua, including the Primavera Gold-Copper Porphyry Project, Cerro Aeropuerto Project, and Santa Maria Gold-Silver Project. It also holds interests in the El Limon and La Libertad gold mines, the Pavon gold project, and other mineral concessions in Nicaragua. The company was formerly known as TLC Ventures Corp. and changed its name to Calibre Mining Corp. in June 2007. Calibre Mining Corp. was founded in 1969 and is headquartered in Vancouver, Canada.

#2 - Motus GI

NASDAQ:MOTS
Stock Price: $1.39 (-$0.10)
PE Ratio: -1.96
Market Cap: $44.82 million
Average Trading Volume: 4.19 million shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.40 (72.7% Upside)

Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.

#3 - CohBar

NASDAQ:CWBR
Stock Price: $1.60 (+$0.11)
PE Ratio: -4.71
Market Cap: $92.74 million
Average Trading Volume: 762,744 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $5.38 (235.9% Upside)

CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes mellitus, cancer, atherosclerosis, cardiovascular, and neurodegenerative diseases, such as Alzheimer's disease. Its lead MBT candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial-derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases, CB5064 analogs for COVID-19 associated ARDS, MBT5 analogs for CXCR4-related cancer and orphan diseases, and MBT3 analogs for cancer immunotherapy. The company was founded in 2007 and is headquartered in Menlo Park, California.

#4 - 9 Meters Biopharma

NASDAQ:NMTR
Stock Price: $1.76 (-$0.08)
Market Cap: $264.57 million
Average Trading Volume: 11.38 million shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $5.25 (198.3% Upside)

9 Meters Biopharma, Inc., a clinical-stage biotechnology company, focuses on patients with rare disorders and unmet needs. The company's pipeline includes drug candidates for short bowel syndrome (SBS) and celiac disease. It is developing NM-002, a long-acting injectable GLP-1 agonist that is in a Phase 2 clinical trial for SBS; and Larazotide, a Phase 3-stage therapeutic in development for celiac disease. The company also develops NM-003, a proprietary long-acting GLP-2 agonist; and NM-004, a double-cleaved mesalamine with an immunomodulator for developing rare and/or orphan indications. 9 Meters Biopharma, Inc. is based in Raleigh, North Carolina.

#5 - Geron

NASDAQ:GERN
Stock Price: $1.79 (-$0.04)
PE Ratio: -5.11
Market Cap: $570.17 million
Average Trading Volume: 4.11 million shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $4.00 (123.5% Upside)

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It holds rights to imetelstat, a telomerase inhibitor in Phase 2/3 clinical trials, which inhibits the uncontrolled proliferation of malignant progenitor cells in hematologic myeloid malignancies to reduce dysfunctional blood cell production and enable recovery of normal blood cell production. The company was founded in 1990 and is headquartered in Menlo Park, California.

#6 - Daré Bioscience

NASDAQ:DARE
Stock Price: $1.96 (-$0.06)
PE Ratio: -2.18
Market Cap: $81.53 million
Average Trading Volume: 3.40 million shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $5.42 (176.4% Upside)

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women's health in the United States. The company intends to develop therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel formulated with clindamycin phosphate 2% to treat bacterial vaginosis in a single application that completed Phase 3 clinical trials; Ovaprene, a hormone-free, monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone replacement therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ORB-204 and ORB-214 injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company is based in San Diego, California.

#7 - Akbank T.A.S.

OTCMKTS:AKBTY
Stock Price: $1.42 (-$0.29)
Market Cap: $3.69 billion
Average Trading Volume: 10,243 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A

Akbank T.A.S., together with its subsidiaries, provides various banking products and services in Turkey and internationally. It operates through three segments: Retail Banking; Commercial Banking, SME Banking, Corporate-Investment and Private Banking; and Treasury. The company's retail banking services comprise deposit accounts, retail loans, commercial installment loans, credit cards, insurance products, and asset management services, as well as bank cards, investment funds trading, automatic payment, foreign currency trading, safe deposit box rental, cheques, money transfer, investment banking, and telephone and Internet banking. It also offers services to large, medium, and small size corporate and commercial customers that include Turkish Lira (TL) and foreign currency denominated working capital loans, foreign trade financing, derivative instruments for hedging purposes of foreign currency and interest risk, letters of credit, foreign currency trading, corporate finance, and deposit and cash management services, as well as project finance loans; and timely and permanent solutions for corporate customers' working capital management, delivering cash management services based on customers' requests that include collection and payment services and liquidity and information management. In addition, the company engages in treasury activities consisting of TL and foreign currency spot and forward transactions, treasury and government bonds, Eurobonds, and private sector bond transactions, as well as derivative trading activities; and marketing and pricing activities related treasury products. Further, it provides bancassurance, asset management, and financial leasing services, as well as offers payment services and issues electronic money. As of December 31, 2019, the company operated 770 branches, as well as approximately 5,100 ATMs and 600,000 POS terminals. Akbank T.A.S. was founded in 1948 and is headquartered in Istanbul, Turkey.

#8 - Argonaut Gold

OTCMKTS:ARNGF
Stock Price: $1.76 (-$0.06)
Average Trading Volume: 205,110 shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $4.79 (172.3% Upside)

Argonaut Gold Inc. engages in the mining, mine development, and mineral exploration activities in North America. It primarily explores for gold and silver deposits. Its primary assets are the El Castillo mine and San Agustin mine, which together form the El Castillo Complex located in Durango, Mexico; the La Colorada mine located in Sonora, Mexico; and the Florida Canyon mine in Nevada, the United States. The company's advanced exploration projects include the Magino project located in Ontario, Canada; and the Cerro del Gallo project in Guanajuato, Mexico. In addition, it holds various other exploration stage projects located in North America. The company is based in Reno, Nevada.

#9 - Marathon Gold

OTCMKTS:MGDPF
Stock Price: $1.91 (+$0.03)
Average Trading Volume: 115,026 shares
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $4.04 (111.3% Upside)

Marathon Gold Corporation engages in the acquisition, exploration, and development of mineral resource projects in Canada. The company explores for gold, and precious and base metal deposits. Its flagship property is the Valentine Lake gold property located in Newfoundland and Labrador, Canada. The company was incorporated in 2009 and is headquartered in Toronto, Canada.

#10 - Serco Group

OTCMKTS:SECCF
Stock Price: $1.93
Average Trading Volume: 7,314 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A

Serco Group plc provides public services in the United Kingdom, Europe, North America, the Asia Pacific, and the Middle East. The company offers base and operational support engineering, and management and information, as well as nuclear, space, and maritime services for the defense sector; and custodial, immigration detention, and detainee transport and monitoring services for the justice and immigration sectors. It also provides rail, ferry, and cycle operations; road traffic management; and air traffic control services to the transportation sector, as well as integrated facilities management, pathology and non-clinical support, and patient administration and contact services for the health sector. In addition, the company offers citizen services, including contact centers and case management; middle, back office, and IT; and employment and skills services. The company serves the United Kingdom and Canadian governments, devolved authorities, and other public sector customers; and federal and civilian agencies, and various state and municipal governments. Serco Group plc was founded in 1929 and is based in Hook, the United Kingdom.

#11 - Tamarack Valley Energy

OTCMKTS:TNEYF
Stock Price: $1.76
Average Trading Volume: 51,915 shares
Consensus Rating: Buy (8 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.50 (41.9% Upside)

Tamarack Valley Energy Ltd. engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids in the Western Canadian sedimentary basin. It primarily holds interests in Alberta Cardium light oil plays in Wilson Creek/Alder Flats/Pembina, and Garrington and Lochend areas in Alberta; Viking light oil resource plays in Redwater in Alberta, as well as in the Veteran, Consort, and Esther area of southeast Alberta and North Hoosier, Milton, and Coleville area of southwest Saskatchewan; Barons and Banff light oil plays located in the Penny area of Southern Alberta; and heavy oil properties. The company was formerly known as Tango Energy Inc. and changed its name to Tamarack Valley Energy Ltd. in June 2010. Tamarack Valley Energy Ltd. is headquartered in Calgary, Canada.

#12 - CES Energy Solutions

OTCMKTS:CESDF
Stock Price: $1.39 (+$0.04)
Average Trading Volume: 44,311 shares
Consensus Rating: Buy (7 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.11 (51.5% Upside)

CES Energy Solutions Corp., together with its subsidiaries, provides consumable chemical solutions throughout the life-cycle of the oilfield. It provides solutions at the drill-bit, at the point of completion and stimulation, at the wellhead and pump-jack, and through to the pipeline and midstream market. The company's solutions include corrosion inhibitors, demulsifiers, H2S scavengers, paraffin control products, surfactants, scale inhibitors, biocides, and other specialty products. It also designs and implements drilling fluid systems and completion solutions for oil and gas producers; and designs and manufactures production and specialty chemicals for use in the oil and natural gas production markets, the stimulation and fracturing markets, and the pipeline and midstream markets. In addition, the company provides environmental consulting, water management services, and drilling fluids waste disposal services primarily to oil and gas producers; and trucks and trailers to transport products in the oil and gas industry. It serves oil and natural gas industry, including multinational producers, intermediate oil and natural gas operators, independent juniors, and joint ventures, as well as pipeline and mid-stream markets in western Canada and the United States. The company was formerly known as Canadian Energy Services & Technology Corp. and changed its name to CES Energy Solutions Corp. in June 2017. CES Energy Solutions Corp. was incorporated in 1986 and is headquartered in Calgary, Canada.

#13 - Stagecoach Group

OTCMKTS:SAGKF
Stock Price: $1.34
Market Cap: $768.28 million
Average Trading Volume: 2,048 shares
Consensus Rating: Buy (6 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A

Stagecoach Group plc, together with its subsidiaries, provides public transportation services in the United Kingdom. It operates through three segments: UK Bus (Regional Operations), UK Bus (London), and UK Rail. The company offers bus, coach, rail, and tram services. It operates city buses primarily in Liverpool, Newcastle, Hull, Manchester, Oxford, Sheffield, Cambridge, and Exeter through a fleet of approximately 7,100 buses and coaches; inter-urban services linking major towns within its regional operating areas, as well as megabus.com, an inter-city coach service; and buses from 10 depots with a fleet of approximately 1,150 buses serving routes in and around east and south-east London. The company also operates Sheffield Supertram, a 28 km light rail network with three routes in the city of Sheffield. It serves individuals, local authorities, transport authorities, and the United Kingdom department for transport. The company was founded in 1980 and is headquartered in Perth, the United Kingdom.

#14 - Isoray

NYSEAMERICAN:ISR
Stock Price: $1.26 (-$0.04)
PE Ratio: -25.20
Market Cap: $177.91 million
Average Trading Volume: 18.09 million shares
Consensus Rating: Buy (4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $1.96 (55.8% Upside)

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.

#15 - T2 Biosystems

NASDAQ:TTOO
Stock Price: $1.78 (-$0.06)
PE Ratio: -2.58
Market Cap: $263.36 million
Average Trading Volume: 14.41 million shares
Consensus Rating: Buy (4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.83 (59.0% Upside)

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance technology that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument for detecting pathogens associated with sepsis and Lyme disease, and other applications, as well as T2Candida Panel that identifies the species of Candida, a fungal pathogen known to cause sepsis directly from whole blood. In addition, it provides T2Bacteria Panel, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2SARS-CoV-2 Panel, a COVID-19 molecular diagnostic test; and T2Resistance Panel for the early and sensitive detection of carbapenemase-resistance markers. Further, it develops T2Cauris Panel, a multi-drug resistant pathogen; and T2Lyme Panel for the detection of various strains of Lyme disease-causing bacteria. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease; and Allergan Sales, LLC to develop detection diagnostic test panel that adds one additional bacteria species to the existing T2Bacteria product candidate, as well as for testing drug resistance directly in whole blood. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.

#16 - Allena Pharmaceuticals

NASDAQ:ALNA
Stock Price: $1.66
PE Ratio: -1.32
Market Cap: $94.42 million
Average Trading Volume: 2.52 million shares
Consensus Rating: Buy (4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $10.40 (526.5% Upside)

Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic that is in phase 3 clinical program for the treatment of hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and moderate to severe chronic kidney diseases. Allena Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Newton, Massachusetts.

#17 - Roxgold

OTCMKTS:ROGFF
Stock Price: $1.37 (-$0.08)
Average Trading Volume: 75,469 shares
Consensus Rating: Buy (4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.36 (72.3% Upside)

Roxgold Inc., a gold mining company, engages in the exploration, evaluation, and development of mineral properties. It holds interest in the Yaramoko gold project located in the Houndé greenstone belt of Burkina Faso, West Africa; and 100% interest in the Séguéla gold project that includes 11 exploration permits situated in Côte d'Ivoire. The company is headquartered in Toronto, Canada.

#18 - Western Forest Products

OTCMKTS:WFSTF
Stock Price: $1.51 (+$0.06)
Average Trading Volume: 46,378 shares
Consensus Rating: Buy (4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $1.94 (28.5% Upside)

Western Forest Products Inc. operates as an integrated softwood forest products company. It is involved in the timber harvesting, sawmilling logs into specialty lumber, value-added lumber remanufacturing, and lumber purchasing and wholesaling. The company offers various products for outdoor living space, such as structures, decking, landscaping, and fencing; home components, including appearance and structural timbers, Japanese housing, and framing, as well as siding, paneling, trim, and soffits; and furniture, moldings, and decorative purpose, as well as doors, windows, and stair components. It also provides its products for cross arms and transmission arms, mat stock, bridges, docks and railway ties, and packaging and crating; and architectural fixtures, lam stock, and timbers. The company sells its products in Canada, the United States, China, Japan, Europe, and internationally. Western Forest Products Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.

#19 - OceanaGold

OTCMKTS:OCANF
Stock Price: $1.63 (-$0.04)
Average Trading Volume: 104,363 shares
Consensus Rating: Buy (5 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $3.92 (140.5% Upside)

OceanaGold Corporation, a gold producer, engages in the exploration, development, and operation of mineral properties. It explores for gold, copper, silver, and other minerals. The company operates the Didipio gold-copper mine located in the Nueva Vizcaya and Quirino provinces on the island of Luzon in the Philippines; the Macraes goldfield mine on the South Island of New Zealand; the Waihi gold mine on the North Island of New Zealand; and Haile gold mine located in South Carolina, the United States. It also has a pipeline of exploration opportunities in the Americas and the Asia-Pacific regions. The company was incorporated in 2003 and is headquartered in Melbourne, Australia.

#20 - Trican Well Service

OTCMKTS:TOLWF
Stock Price: $1.63 (+$0.02)
Average Trading Volume: 24,807 shares
Consensus Rating: Buy (2 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.08 (27.8% Upside)

Trican Well Service Ltd., an equipment services company, provides various specialized products, equipment, services, and technology for use in the drilling, completion, stimulation, and reworking of oil and gas wells primarily in Canada. The company offers cementing solutions, including pre-flushes and spacers, cement plugs, lost circulation, cement design solutions, and laboratory solutions, as well as surface, intermediate, production, liner, horizontal, and remedial/squeeze cementing services; and cement pumpers, bulk equipment, and cement auxiliary equipment. It also provides reservoir solutions, such as exploration, production analysis, and simulation and modeling services; coiled tubing solutions that include coiled tubing fracturing and acidizing, specially designed tools, in-house engineering, well cleanouts, milling, high pressure jetting, e-coil (smart coil), nitrogen gas lifting, and production enhancement, as well as equipment and tools; and acidizing and production enhancement services comprising production and injection well enhancement services, and equipment. In addition, the company offers pipeline services comprising nitrogen, commissioning, operating, and abandonment services; well intervention tools; fracturing solutions and equipment; and industrial services, such as chemical, mechanical, and bundle cleaning services. Trican Well Service Ltd. was founded in 1979 and is headquartered in Calgary, Canada.

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

• Best-in-Class Portfolio Monitoring

  View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

• Stock Ideas and Recommendations

  Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

• Advanced Stock Screeners and Research Tools

  Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here